2020-10-15 |
2020-10-13 |
B
Purchase
|
Societe des Produits Nestle S.A.
Major owner
|
10,681,704
+83.9%
34.50
368,518,788
USD
|
10,681,704
+83.9%
|
34.50
|
368,518,788
USD
|
|
2020-10-15 |
2020-10-13 |
B
Purchase
|
Societe des Produits Nestle S.A.
Major owner
|
43,435,583
+inf%
34.50
1,498,527,614
USD
|
43,435,583
+inf%
|
34.50
|
1,498,527,614
USD
|
|
2020-03-19 |
2020-03-18 |
B
Purchase
|
ENRIGHT PATRICK G
Non-Executive Director
|
16,213
+29.8%
11.06
179,345
USD
|
16,213
+29.8%
|
11.06
|
179,345
USD
|
|
2020-03-19 |
2020-03-17 |
B
Purchase
|
ENRIGHT PATRICK G
Non-Executive Director
|
8,787
+19.3%
11.50
101,051
USD
|
8,787
+19.3%
|
11.50
|
101,051
USD
|
|
2020-03-19 |
2020-03-17 |
B
Purchase
|
ENRIGHT PATRICK G
Non-Executive Director
|
100,000
+1.7%
11.40
1,139,650
USD
|
100,000
+1.7%
|
11.40
|
1,139,650
USD
|
|
2020-03-17 |
2020-03-13 |
B
Purchase
|
Oxtoby Andrew
Chief Commercial Officer
Officer
|
3,000
+13.6%
14.76
44,266
USD
|
3,000
+13.6%
|
14.76
|
44,266
USD
|
|
2020-03-12 |
2020-03-12 |
B
Purchase
|
BJERKHOLT ERIC
Chief Financial Officer
Officer
|
1,000
+2.4%
15.10
15,100
USD
|
1,000
+2.4%
|
15.10
|
15,100
USD
|
|
2020-03-10 |
2020-03-10 |
B
Purchase
|
Dallas Jayson Donald Alexander
President and CEO
Executive Director
|
2,665
+2.2%
18.74
49,934
USD
|
2,665
+2.2%
|
18.74
|
49,934
USD
|
|
2020-03-10 |
2020-03-09 |
B
Purchase
|
BJERKHOLT ERIC
Chief Financial Officer
Officer
|
1,000
+2.4%
18.97
18,970
USD
|
1,000
+2.4%
|
18.97
|
18,970
USD
|
|
2020-04-24 |
2020-02-07 |
B
Purchase
|
Societe des Produits Nestle S.A.
Major owner
|
525,634
+inf%
319.68
168,032,049
USD
|
525,634
+inf%
|
319.68
|
168,032,049
USD
|
|
2020-04-24 |
2020-02-07 |
B
Purchase
|
Societe des Produits Nestle S.A.
Major owner
|
1,000,000
+8.5%
31.97
31,970,000
USD
|
1,000,000
+8.5%
|
31.97
|
31,970,000
USD
|
|
2020-01-21 |
2020-01-16 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
400
-0.9%
37.00
14,800
USD
|
400
-0.9%
|
37.00
|
14,800
USD
|
|
2020-01-03 |
2020-01-02 |
PS
Planned sale
|
ADELMAN DANIEL C MD
Chief Medical Officer
|
20,000
-48.5%
35.00
700,038
USD
|
20,000
-48.5%
|
35.00
|
700,038
USD
|
|
2019-12-30 |
2019-12-26 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
10,000
-18.0%
33.03
330,322
USD
|
10,000
-18.0%
|
33.03
|
330,322
USD
|
|
2019-12-11 |
2019-12-09 |
PS
Planned sale
|
ADELMAN DANIEL C MD
Chief Medical Officer
Officer
|
20,000
-48.5%
30.04
600,716
USD
|
20,000
-48.5%
|
30.04
|
600,716
USD
|
|
2019-09-20 |
2019-09-18 |
B
Purchase
|
BJERKHOLT ERIC
Chief Financial Officer
|
1,550
+4.8%
22.57
34,977
USD
|
1,550
+4.8%
|
22.57
|
34,977
USD
|
|
2020-04-24 |
2018-11-28 |
B
Purchase
|
Nestle Health Science US Holdings, Inc.
Major owner
|
3,237,529
+38.1%
30.27
98,000,003
USD
|
3,237,529
+38.1%
|
30.27
|
98,000,003
USD
|
|
2018-11-21 |
2018-11-19 |
S
Sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
40,000
-81.0%
30.04
1,201,600
USD
|
40,000
-81.0%
|
30.04
|
1,201,600
USD
|
|
2018-11-19 |
2018-11-19 |
B
Purchase
|
Dallas Jayson Donald Alexander
President and CEO
Executive Director
|
50
+0.1%
27.56
1,378
USD
|
50
+0.1%
|
27.56
|
1,378
USD
|
|
2018-11-19 |
2018-11-19 |
B
Purchase
|
Dallas Jayson Donald Alexander
President and CEO
Executive Director
|
3,600
+6.0%
27.56
99,209
USD
|
3,600
+6.0%
|
27.56
|
99,209
USD
|
|
2018-06-14 |
2018-06-13 |
PP
Planned purchase
|
BJERKHOLT ERIC
Chief Financial Officer
|
1,600
+8.9%
30.41
48,663
USD
|
1,600
+8.9%
|
30.41
|
48,663
USD
|
|
2018-06-13 |
2018-06-11 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
President and CEO
Executive Director
|
29,457
-8.5%
30.83
908,301
USD
|
29,457
-8.5%
|
30.83
|
908,301
USD
|
|
2018-06-08 |
2018-06-08 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
President and CEO
Executive Director
|
42,106
-11.8%
30.70
1,292,511
USD
|
42,106
-11.8%
|
30.70
|
1,292,511
USD
|
|
2018-06-08 |
2018-06-07 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
President and CEO
Executive Director
|
500
-0.2%
31.58
15,790
USD
|
500
-0.2%
|
31.58
|
15,790
USD
|
|
2018-06-08 |
2018-06-07 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
President and CEO
Executive Director
|
32,098
-9.2%
30.95
993,321
USD
|
32,098
-9.2%
|
30.95
|
993,321
USD
|
|
2018-06-08 |
2018-06-06 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
President and CEO
Executive Director
|
30,465
-8.8%
31.20
950,371
USD
|
30,465
-8.8%
|
31.20
|
950,371
USD
|
|
2018-06-05 |
2018-06-05 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
See Remarks
Executive Director
|
38,825
-11.0%
31.83
1,235,835
USD
|
38,825
-11.0%
|
31.83
|
1,235,835
USD
|
|
2018-06-05 |
2018-06-04 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
See Remarks
Executive Director
|
2,612
-0.8%
32.74
85,519
USD
|
2,612
-0.8%
|
32.74
|
85,519
USD
|
|
2018-06-05 |
2018-06-04 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
See Remarks
Executive Director
|
62,740
-16.5%
31.84
1,997,836
USD
|
62,740
-16.5%
|
31.84
|
1,997,836
USD
|
|
2018-06-05 |
2018-06-01 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
See Remarks
Executive Director
|
2,498
-0.8%
33.19
82,899
USD
|
2,498
-0.8%
|
33.19
|
82,899
USD
|
|
2018-06-05 |
2018-06-01 |
PS
Planned sale
|
DILLY STEPHEN GEORGE
See Remarks
Executive Director
|
58,699
-15.6%
32.59
1,913,094
USD
|
58,699
-15.6%
|
32.59
|
1,913,094
USD
|
|
2018-05-24 |
2018-05-22 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
1,648
-4.7%
33.00
54,384
USD
|
1,648
-4.7%
|
33.00
|
54,384
USD
|
|
2018-05-24 |
2018-05-22 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
1,648
-4.7%
33.00
54,384
USD
|
1,648
-4.7%
|
33.00
|
54,384
USD
|
|
2018-03-06 |
2018-03-05 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
700
-2.1%
36.60
25,618
USD
|
700
-2.1%
|
36.60
|
25,618
USD
|
|
2018-03-06 |
2018-03-05 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
948
-2.8%
35.52
33,674
USD
|
948
-2.8%
|
35.52
|
33,674
USD
|
|
2018-03-06 |
2018-03-05 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
1,875
-5.5%
37.00
69,375
USD
|
1,875
-5.5%
|
37.00
|
69,375
USD
|
|
2018-03-05 |
2018-03-01 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,807
-93.3%
33.10
59,812
USD
|
1,807
-93.3%
|
33.10
|
59,812
USD
|
|
2020-04-24 |
2018-02-26 |
B
Purchase
|
Nestle Health Science US Holdings, Inc.
Major owner
|
937,500
+12.4%
32.00
30,000,000
USD
|
937,500
+12.4%
|
32.00
|
30,000,000
USD
|
|
2018-02-26 |
2018-02-26 |
B
Purchase
|
BJERKHOLT ERIC
Chief Financial Officer
Officer
|
3,125
+62.5%
32.00
100,000
USD
|
3,125
+62.5%
|
32.00
|
100,000
USD
|
|
2018-02-26 |
2018-02-26 |
B
Purchase
|
FALBERG KATHRYN E
Non-Executive Director
|
30,000
+31.6%
32.00
960,000
USD
|
30,000
+31.6%
|
32.00
|
960,000
USD
|
|
2018-02-26 |
2018-02-26 |
B
Purchase
|
Iwicki Mark T
Non-Executive Director
|
9,375
+46.9%
32.00
300,000
USD
|
9,375
+46.9%
|
32.00
|
300,000
USD
|
|
2018-02-26 |
2018-02-22 |
B
Purchase
|
ENRIGHT PATRICK G
Non-Executive Director
Major owner
|
15,593
+214.3%
32.00
498,976
USD
|
15,593
+214.3%
|
32.00
|
498,976
USD
|
|
2018-02-26 |
2018-02-22 |
B
Purchase
|
Tammenoms Bakker Juliet
Major owner
|
9,375
+128.8%
32.00
300,000
USD
|
9,375
+128.8%
|
32.00
|
300,000
USD
|
|
2018-02-07 |
2018-02-05 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
1,648
-100.0%
35.87
59,114
USD
|
1,648
-100.0%
|
35.87
|
59,114
USD
|
|
2018-02-05 |
2018-02-01 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
Officer
|
4,292
-97.1%
35.58
152,703
USD
|
4,292
-97.1%
|
35.58
|
152,703
USD
|
|
2018-02-05 |
2018-02-01 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
Officer
|
2,300
-34.2%
34.95
80,385
USD
|
2,300
-34.2%
|
34.95
|
80,385
USD
|
|
2018-01-26 |
2018-01-24 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
1,875
-100.0%
38.15
71,531
USD
|
1,875
-100.0%
|
38.15
|
71,531
USD
|
|
2018-01-16 |
2018-01-16 |
PS
Planned sale
|
ADELMAN DANIEL C MD
Chief Medical Officer
Officer
|
9,933
-100.0%
40.00
397,320
USD
|
9,933
-100.0%
|
40.00
|
397,320
USD
|
|
2018-01-16 |
2018-01-12 |
PS
Planned sale
|
ADELMAN DANIEL C MD
Chief Medical Officer
Officer
|
26,784
-100.0%
40.00
1,071,360
USD
|
26,784
-100.0%
|
40.00
|
1,071,360
USD
|
|
2018-01-08 |
2018-01-04 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
Officer
|
1,648
-100.0%
37.33
61,520
USD
|
1,648
-100.0%
|
37.33
|
61,520
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
600
-100.0%
37.75
22,652
USD
|
600
-100.0%
|
37.75
|
22,652
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
24,400
-97.6%
37.12
905,716
USD
|
24,400
-97.6%
|
37.12
|
905,716
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
300
-1.2%
37.86
11,359
USD
|
300
-1.2%
|
37.86
|
11,359
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
24,700
-49.4%
37.13
917,022
USD
|
24,700
-49.4%
|
37.13
|
917,022
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
599
-1.2%
37.78
22,629
USD
|
599
-1.2%
|
37.78
|
22,629
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Barrowcliffe Susan E.
General Manager, Europe
Officer
|
24,401
-32.5%
37.12
905,811
USD
|
24,401
-32.5%
|
37.12
|
905,811
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
Officer
|
1,601
-92.5%
37.08
59,367
USD
|
1,601
-92.5%
|
37.08
|
59,367
USD
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
Officer
|
4,990
-74.3%
37.12
185,223
USD
|
4,990
-74.3%
|
37.12
|
185,223
USD
|
|
2017-12-29 |
2017-12-27 |
PS
Planned sale
|
ADELMAN DANIEL C MD
Chief Medical Officer
|
3,283
-100.0%
40.00
131,320
USD
|
3,283
-100.0%
|
40.00
|
131,320
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
3,600
-96.5%
39.15
140,949
USD
|
3,600
-96.5%
|
39.15
|
140,949
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
6,400
-63.2%
38.73
247,848
USD
|
6,400
-63.2%
|
38.73
|
247,848
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,200
-10.6%
39.28
47,134
USD
|
1,200
-10.6%
|
39.28
|
47,134
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
8,800
-43.7%
38.83
341,663
USD
|
8,800
-43.7%
|
38.83
|
341,663
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
700
-3.4%
39.26
27,479
USD
|
700
-3.4%
|
39.26
|
27,479
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
4,310
-17.1%
38.80
167,239
USD
|
4,310
-17.1%
|
38.80
|
167,239
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,500
-5.6%
39.23
58,847
USD
|
1,500
-5.6%
|
39.23
|
58,847
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
11,000
-29.2%
38.82
427,043
USD
|
11,000
-29.2%
|
38.82
|
427,043
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,500
-3.8%
39.25
58,875
USD
|
1,500
-3.8%
|
39.25
|
58,875
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
11,000
-21.9%
38.83
427,115
USD
|
11,000
-21.9%
|
38.83
|
427,115
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,800
-3.5%
39.23
70,605
USD
|
1,800
-3.5%
|
39.23
|
70,605
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
10,700
-17.1%
38.82
415,322
USD
|
10,700
-17.1%
|
38.82
|
415,322
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
1,500
-2.3%
39.25
58,878
USD
|
1,500
-2.3%
|
39.25
|
58,878
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Rozenman Mary M.
See Remarks
|
11,000
-14.6%
38.83
427,089
USD
|
11,000
-14.6%
|
38.83
|
427,089
USD
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
1,875
-100.0%
39.44
73,950
USD
|
1,875
-100.0%
|
39.44
|
73,950
USD
|
|
2017-12-06 |
2017-12-04 |
PS
Planned sale
|
Sheehy Douglas T.
See Remarks
|
1,906
-100.0%
38.66
73,686
USD
|
1,906
-100.0%
|
38.66
|
73,686
USD
|
|